Coign Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Coign Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$697K	Buy	1,391 +15	+1%	+$7.2K	0.31%	55
2026 Q1	$676K	Buy	1,376 +4	+0.3%	+$2.17K	0.36%	55
2025 Q4	$795K	Buy	1,372 +10	+0.7%	+$5.66K	0.42%	45
2025 Q3	$660K	Buy	1,362 +123	+10%	+$57.3K	0.36%	59
2025 Q2	$502K	Buy	1,239 +36	+3%	+$15.1K	0.34%	68
2025 Q1	$598K	Buy	1,203 +13	+1%	+$7.04K	0.46%	52
2024 Q4	$619K	Buy	+1,190	New	+$654K	0.57%	44

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Coign Capital Advisors's TMO Position: Q2 2026 in Review

Coign Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, buying an estimated $7.2K and bringing the position to 1,391 shares worth $697K. The position accounts for 0.31% of the portfolio, ranked #55.

Coign Capital Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $795K in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Coign Capital Advisors held 1,391 shares of Thermo Fisher Scientific worth $697K as of Q2 2026.
Coign Capital Advisors bought 15 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.2K.
Thermo Fisher Scientific made up 0.31% of Coign Capital Advisors's portfolio in Q2 2026, its #55 holding.
Coign Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Coign Capital Advisors's Thermo Fisher Scientific position peaked at $795K in Q4 2025.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Coign Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.